ClinVar, the NCBI archive connecting genetic variants to clinical phenotypes

Bioinformatics & Databases Schema: DefinedTerm

Definition

A public archive of relationships between human genetic variants and clinical phenotypes, maintained by NCBI. In primer design, ClinVar data identifies whether a primer binding site overlaps clinically significant variants, which is essential for diagnostic assay design. Primers in clinically relevant regions require extra scrutiny to ensure they do not preferentially amplify or miss pathogenic alleles.

Content and Classification

ClinVar aggregates submissions from clinical testing laboratories (including Invitae, Ambry, GeneDx), research consortia (including ClinGen), and literature curation efforts (including OMIM and UniProt). Each variant is classified into one of five categories using standardized ACMG/AMP guidelines: Pathogenic (P), Likely Pathogenic (LP), Uncertain Significance (VUS), Likely Benign (LB), and Benign (B). The classification considers multiple evidence types: population frequency (from gnomAD), computational predictions (PolyPhen, SIFT, CADD), functional studies, segregation analysis, and de novo occurrence. Variants of Uncertain Significance represent a major clinical challenge — up to 40% of reported variants in some genes receive VUS classification, requiring further familial or functional studies for reclassification.

Clinical Applications

ClinVar is essential for clinical genomics interpretation. When sequencing a patient's genome, detected variants are cross-referenced against ClinVar to determine pathogenicity. Pathogenic variants in disease-associated genes guide diagnosis, prognosis, and treatment selection. In cancer genomics, somatic variants are compared against ClinVar's oncology-focused submissions. The database also supports pharmacogenomic interpretation — variants in CYP2C19, CYP2D6, and other drug-metabolism genes guide medication selection and dosing. The ClinGen consortium works to resolve conflicting interpretations through expert panel review. Variants should be interpreted in the context of the specific testing indication — a variant pathogenic for hypertrophic cardiomyopathy may have different implications in an asymptomatic individual versus a patient with cardiomyopathy symptoms.

In Practice

ClinVar is widely used in bioinformatics & databases and related fields. Key applications include:

  • Research and experimental design in molecular biology laboratories
  • Clinical diagnostics and therapeutic development pipelines
  • Automated validation within VigyanLLM's 24-step primer design and analysis framework

Frequently Asked Questions

What is ClinVar?

ClinVar (NCBI) archives relationships between genetic variants and clinical phenotypes. In primer design, it identifies primers overlapping clinically significant variants for diagnostic assay validation. Explore the full definition and applications on this page.

How does ClinVar relate to dbSNP?

ClinVar is closely connected to dbSNP and other Bioinformatics & Databases concepts. Understanding these relationships is essential for comprehensive knowledge in molecular biology and bioinformatics.

How does VigyanLLM use ClinVar in its pipeline?

VigyanLLM's 24-step validated pipeline incorporates ClinVar as part of its rigorous quality control framework. The platform automates checks related to ClinVar to ensure primer design accuracy, specificity, and reliability for research and clinical applications.

VigyanLLM Application

VigyanLLM's validated pipeline addresses dbsnp and ClinVar through automated computational checks. Explore how the platform handles ClinVar across its 24-step framework:

Explore on VigyanLLM → Primer Design Best Practices → Primer3 Alternative → qPCR Primer Design →